Arkolith/Insider Trading/MDLN/Form 4

Abrams William J

See RemarksMedline Inc. (MDLN) · full profile →Form 4 · filed Mar 6, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
3 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 5, 2026Grant(A)18K—$018K
Dec 16, 2025Grant(A)31K——31K
Dec 16, 2025Grant(A)496K——496K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 16, 2025Grant(A)1.1M——1.1M
Dec 16, 2025Grant(A)31K——31K
Dec 16, 2025Grant(A)98K——98K
Dec 16, 2025Grant(A)496K——496K
Dec 16, 2025Grant(A)91K——91K
Dec 16, 2025Grant(A)170K——170K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-096659) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML